EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

Parvovirus B19 infection as a trigger of acute cholestasis in heterozygous genetic BSEP deficiency: a case report and review of the literature of acute parvovirus B19-related hepatitis

Madalina-Gabriela Indre, Giovanni Vitale, Amalia Conti, Maria Boe, Deborah Malvi, Simona Ferrari, Mariarosaria Marseglia, Liliana Gabrielli, Tiziana Lazzarotto, Fabio Piscaglia

Internal and Emergency Medicine · 2026-11 · 21 (8) · 2799-2816

DOI: 10.1007/s11739-026-04464-1 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Internal and Emergency Medicine, online erschienen am 24.07.2026. Verfasst von Madalina-Gabriela Indre und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, 40138, Bologna, Italy. madalina.indre@unibo.it. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily B, Member 11, Parvovirus B19, Human, Parvoviridae Infections, Cholestasis. Die Arbeit nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agenzia Italiana del Farmaco, Ministero della Salute, Alma Mater Studiorum - Università di Bologna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bile salt export pump (BSEP) deficiency, also termed progressive familial intrahepatic cholestasis type 2 (PFIC2), is a rare genetic disorder caused by mutations in the ATP-binding cassette, sub-family B member 11 (ABCB11) gene, predisposing to cholestasis and progressive liver damage. Although parvovirus B19 is a recognized but rare cause of acute hepatitis in children, its role in adult liver disease remains uncertain. To expand the knowledge on this topic, we performed a narrative review of published adult cases of B19-associated hepatitis and report the case of a 46-year-old immunocompetent man who developed acute cholestatic hepatitis during B19 infection. The clinical course was not fully attributable to the viral insult alone, prompting further evaluation. Liver histology demonstrated marked loss of BSEP immunoreactivity, and genetic testing identified a heterozygous ABCB11 variant. Despite treatment with ursodeoxycholic acid and cholestyramine, the symptoms persisted, leading to the introduction of the ileal bile acid transporter (IBAT) inhibitor, odevixibat, which resulted in rapid relief of pruritus and near-complete biochemical normalization within 2 months. Our review identified 32 published adult cases of B19-associated hepatitis. Most patients were immunocompetent, with presentations ranging from mild hepatic dysfunction to fulminant liver failure requiring transplantation. In more than half of the patients, predisposing factors such as hematologic disorders or viral co-infections were identified. This review highlights the importance of considering parvovirus B19 infection in the differential diagnosis of acute hepatitis in adults and of investigating potential underlying predisposing factors when the clinical course cannot be fully explained by the viral infection alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ATP Binding Cassette Transporter, Subfamily B, Member 11Parvovirus B19, HumanParvoviridae InfectionsCholestasisCholestasis, IntrahepaticHumansMaleMiddle Aged

Stichwörter der Autor:innen

ABCB11BSEP deficiencyCholestasisHepatitisParvovirus B19

Substanzen

ATP Binding Cassette Transporter, Subfamily B, Member 11ABCB11 protein, human

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, University of Bologna, 40138, Bologna, Italy. madalina.indre@unibo.it.
  • Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy. madalina.indre@unibo.it.
  • Internal Medicine Unit for the Treatment of Severe Organ Failure, IRCCS AOUBO, 40138, Bologna, Italy.
  • Medical Genetics Unit, IRCCS, Azienda Ospedaliero-Universitaria Di Bologna, 40138, Bologna, Italy.
  • Department of Medical and Surgical Sciences, University of Bologna, 40138, Bologna, Italy.
  • Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.

Förderung

  • Agenzia Italiana del Farmaco, Ministero della Salute
  • Alma Mater Studiorum - Università di Bologna

Zitieren

APA

Indre, M. G., Vitale, G., Conti, A., Boe, M., Malvi, D., Ferrari, S., Marseglia, M., Gabrielli, L., Lazzarotto, T., & Piscaglia, F. (2026). Parvovirus B19 infection as a trigger of acute cholestasis in heterozygous genetic BSEP deficiency: a case report and review of the literature of acute parvovirus B19-related hepatitis. Internal and Emergency Medicine, 21(8), 2799-2816. https://doi.org/10.1007/s11739-026-04464-1

Vancouver

Indre MG, Vitale G, Conti A, Boe M, Malvi D, Ferrari S, et al. Parvovirus B19 infection as a trigger of acute cholestasis in heterozygous genetic BSEP deficiency: a case report and review of the literature of acute parvovirus B19-related hepatitis. Internal and Emergency Medicine. 2026;21(8):2799-2816. doi:10.1007/s11739-026-04464-1

BibTeX
@article{Indre2026,
  author = {Indre, Madalina-Gabriela and Vitale, Giovanni and Conti, Amalia and Boe, Maria and Malvi, Deborah and Ferrari, Simona and Marseglia, Mariarosaria and Gabrielli, Liliana and Lazzarotto, Tiziana and Piscaglia, Fabio},
  title = {Parvovirus B19 infection as a trigger of acute cholestasis in heterozygous genetic BSEP deficiency: a case report and review of the literature of acute parvovirus B19-related hepatitis},
  journal = {Internal and Emergency Medicine},
  year = {2026},
  volume = {21},
  number = {8},
  pages = {2799--2816},
  doi = {10.1007/s11739-026-04464-1}
}
Kostenlos starten →